Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate if neuraxial anesthesia (epidural or intradural anesthesia) used during childbirth is associated with more frequent infectious complications in patients with primary immunodeficiencies (PID).


Clinical Trial Description

Neuraxial anaesthesia (epidural or intradural) is often used to alleviate pain during labour and childbirth. Although extremely efficient and safe, rare but serious infectious complications such as epidural abscess or meningitis can occur afterwards. Patients with PID tend to have a greater risk of infectious complications than the general population. With the progress of medical care in those pathologies, female patients are now giving birth more often. The use of neuraxial anaesthesia and the associated infectious complications have never been studied in this population. The investigators intend to review the medical records of PID patients who gave birth in an APHP hospital in the last 10 years to evaluate the use of neuraxial anesthesia and the frequency of infectious complications associated with neuraxial anesthesia. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06449066
Study type Observational
Source Assistance Publique - Hôpitaux de Paris
Contact Aude Beloeuvre
Phone 00 33 1 58 41 19 08
Email Aude.BELOEUVRE@aphp.fr
Status Not yet recruiting
Phase
Start date June 2024
Completion date November 2024